Botanical species · safety record

Herniaria glabra

The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 adverse-effect record for Herniaria glabra. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Herniaria glabra L.

5Constituent measurements

1Safety records

5Cited sources

11Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 11 licensed products naming Herniaria glabra as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Aerial parts
Fresh aerial parts collected at flowering time
Herb top
Leaf and flower

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Pentacyclic triterpene saponins	Aerial part of plants	Solvent extraction	—	GC-MS	Resolve DOI
Triterpene saponins	Aerial part of plants	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Dillapiole	Unspecified	Essential oil	—	GC-MS	No resolvable identifier
Estragole	Unspecified	Essential oil	—	GC-MS	No resolvable identifier
Triterpene saponins	Aerial part of plants	Fresh	15 Percent	—	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Systemic	Liver	Live plants	Drying (dehydration)	Rat (as animal)	Subchronic	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Rhiouani, Hamid., El-Hilaly, Jaouad., Israili, Zafar H., Lyoussi, Badiaa. Acute and sub-chronic toxicity of an aqueous extract of the leaves of Herniaria glabra in rodents . Journal of ethnopharmacology, 2008, vol. 118, no. 3, p. 378-386. DOI
Khakim, El Mabruki., Klemper, A. V., Kaukhova, I. E., Sorokin, V. V. ESTABLISHMENT OF RUPTUREWORT (HERNIARIA GIABRA) HERB IDENTITY CHARACTERESTICS AND QUALITY INDICES . Farmatsiya (moscow), 2014, no. 6, p. 21-24.
Hethelyi, E. B., Galambosi, B., Szarka, S., Lemberkovics, E., Szoke, E. Phytochemical investigation of medicinal and culinary herbs. Acta agronomica hungarica, 2012, vol. 60, no. 3, p. 201-207.
SCHRODER, H., SCHUBERTZSILAVECZ, M., REZNICEK, G., CART, J., JURENITSCH, J., HASLINGER, E. A TRITERPENE SAPONIN FROM HERNIARIA-GLABRA. Phytochemistry, 1993, vol. 34, no. 6, p. 1609-1613. DOI
Freiler, M., Reznicek, G., Jorenitsch, J., Kubelka, W., Schmidt, W., SchubertZsilavecz, M., Haslinger, E., Reiner, J. New triterpene saponins from Herniaria glabra. Helvetica chimica acta, 1996, vol. 79, no. 2, p. 385-390. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature